Oragenics CEO Alan Joslyn Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal

The Tampa Bay Business Journal recognized Alan Joslyn, president and chief executive officer of UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, for being part of the region’s top health care innovators. The feature was part of the Florida Business Journal’s statewide Future of Health Care special publication published October 23, 2020.

“It’s really important from the current pandemic to develop an effective vaccine to not only control Covid-19, but other viruses down the line. We’ve had other coronaviruses before — SARS and MERS,” Joslyn said during the interview. “Scientists are finding the frequency of these pandemics are increasing. We need to be better prepared and have broader immunity. For years, companies didn’t research new antibiotics classes because of the costs, but it can help create immunity. It’s important to have government support to develop these new antibiotics.”

Learn more about Oragenics CEO Alan Joslyn Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal. – Article behind a paywall.